Dual Inhibition of AlaRS Function by Chelerythrine as a Therapeutic Strategy for Head and Neck Squamous Cell Carcinoma
Our findings demonstrate that CHE exerts dual inhibition of AlaRS function, affecting both canonical translational activity and non-canonical roles in cellular signaling, thereby presenting a robust anti-proliferative effect on HNSCC cells.